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Human bone marrow mesenchymal stem/stromal
cells (MSCs) are multipotent progenitor cells with
multilineage differentiation potentials including os-
teogenesis and adipogenesis.While significant prog-
ress has been made in understanding transcriptional
controls of MSC fate, little is known about how MSC
differentiation is epigenetically regulated. Here we
show that the histone demethylases KDM4B and
KDM6B play critical roles in osteogenic commitment
of MSCs by removing H3K9me3 and H3K27me3.
Depletion of KDM4B or KDM6B significantly reduced
osteogenic differentiation and increased adipogenic
differentiation. Mechanistically, while KDM6B con-
trolled HOX expression by removing H3K27me3,
KDM4B promoted DLX expression by removing
H3K9me3. Importantly, H3K27me3- and H3K9me3-
positive MSCs of bone marrow were significantly
elevated in ovariectomized and aging mice in which
adipogenesis was highly active. Since histone deme-
thylases are chemically modifiable, KDM4B and
KDM6B may present as therapeutic targets for con-
trolling MSC fate choices and lead to clues for
new treatment in metabolic bone diseases such as
osteoporosis.
INTRODUCTION
Human bone marrow mesenchymal/stromal stem cells (MSCs)
are multipotent progenitor cells with self-renewal capabilities
and multilineage differentiation potentials including osteogene-
sis, chondrogenesis, and adipogenesis (Dominici et al., 2006;
Bianco et al., 2008; Caplan, 2007; Levi and Longaker, 2011;
Teitelbaum, 2010). MSCs hold significant promise for regenera-
tive therapies due to their convenient isolation, lack of immuno-50 Cell Stem Cell 11, 50–61, July 6, 2012 ª2012 Elsevier Inc.genicity, and ability to transdifferentiate and to create a tissue
microenvironment favorable for tissue repair (Kolf et al., 2007;
Phinney and Prockop, 2007; Undale et al., 2009). Their thera-
peutic utility hinges upon the understanding of molecular
mechanisms that regulate their differentiation (Tang et al.,
2009; Sacchetti et al., 2007; Medici et al., 2010; Kronenberg,
2010; Huebsch et al., 2010). Normal bone homeostasis relies
on the inverse relation between adipogenesis and osteogenesis
in MSCs. As observed in both healthy and diseased bone, inhibi-
tion of adipogenesis may enhance bone growth and repair
(McCauley, 2010; Kawai and Rosen, 2010). Thus, it is crucial to
gain an understanding of how the MSC lineage is regulated.
Growing evidence suggests that the final cell fate decision of
MSCs relies on an orchestrated activation of lineage-specific
genes and repression of genes promoting cell stemness or
commitment to other lineages (Me´ndez-Ferrer et al., 2010; Ta-
kada et al., 2009; Wei et al., 2011). At present, studies have
been focused on identifying a number of extrinsic regulators
and their downstream transcription factors that control cell fate
commitment (Lian et al., 2006; Karsenty et al., 2009; Phimphilai
et al., 2006). For example, bone morphogenic proteins (BMP)
act as major osteogenic inducers and have been utilized for
promoting bone regeneration and repair (Chen et al., 2004; Med-
ici et al., 2010). While significant progress has been made in
understanding of molecular regulation of MSC differentiation,
very little is known with regard to the epigenetic events that
control MSC commitment to bone, adipose tissue, and cartilage.
Cell fate is determined by DNA-binding transcription factors
that are regulatedmore specifically at the epigenetic level, where
a specific chromatin configuration is conferred to control the
expression of key transcription factors for differentiation (Jenu-
wein and Allis, 2001; Shi, 2007; Agger et al., 2008; Stein et al.,
2010). Progressive restriction of differentiation potential in
MSCs relies on orchestrated activation of repression of lineage-
specific genes (Lian et al., 2006; Kronenberg, 2010). While
epigenetic regulatory mechanisms that govern adipogenic- and
osteogenic-specific genes remain largely elusive, they are the
crucial missing links in understanding extracellular signaling
and lineage-specific decisions during MSC differentiation. One
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Figure 1. KDM4B and KDM6B Were
Induced by BMP/SMAD Signaling in MSCs
(A) BMP4/7-induced histone demethylases in
MSC by gene expression profiling. The mRNA
expression of histone demethylases was as-
sessed by real-time RT-PCR.
(B) The knockdown of SMAD4 by shRNA. SMAD4
expression was examined by western blot
analysis.
(C) The knockdown of SMAD4 inhibited KDM4B in
MSCs. KDM4BmRNA was examined by real-time
RT-PCR.
(D) The knockdown of SMAD4 inhibited KDM6B
expression in MSCs. KDM6B mRNA was as-
sessed by real-time RT-PCR. ** p < 0.01.
(E) The knockdown of SMAD1 by siRNA.
(F) The knockdown of SMAD1 inhibited KDM4B in
MSCs.
(G) The knockdown of SMAD1 inhibited KDM6B
expression inMSCs. ** p<0.01. Seealso FigureS1.
Cell Stem Cell
Epigenetic Control of MSC Fateof the central chromatinmodifications, histone lysinemethylation
at the N-terminal tails, controls the access to regulatory regions
on the DNA by altering chromatin compaction (Jenuwein and
Allis, 2001). Upon differentiation of stem cells, the relative levels
of epigenetic marks change to reflect the activation and repres-
sion of genes, guiding development towards one cell lineage.
Modified histone domains have thus become epigenetic signa-
tures that either mark for gene activation, such as acetylated
histone 3 Lysine 9 (H3K9) and trimethylated Histone 3 Lysine 4
(H3K4), or mark for gene repression, such as trimethylated
H3K9 and trimethylated H3K27 (Shi, 2007; Agger et al., 2008).
Recently, histone demethylases have been discovered to
possess the ability of removing methyl groups from various
methylated histone lysine residues such as K4, K9, K27, K36,
and K79, thereby enabling the dynamic and reversible regulation
of transcription (Klose et al., 2006; Shi and Whetstine, 2007;
Agger et al., 2008). As such, growing evidence suggests that
histone demethylases may be associated with cell fate choices
and cell differentiation (Shi, 2007; Sen et al., 2008; Lan et al.,
2007; Agger et al., 2007, 2009).
Recently, we have identified a demethylase complex regu-
lating the function of MSCs isolated from craniofacial tissues
(Fan et al., 2009). To further explore the role of demethylases
in MSC cell fate determination, we systemically profiled the
expression of histone demethylases in BMP-stimulated MSCs,
as BMPs are potent inducers of osteogenic differentiation
(Chen et al., 2004). We found that BMP4/7 heterodimer rapidly
induced the expression of two histone demethylases, KDM4B
(also known as JMJD2B; Fodor et al., 2006; Cloos et al., 2006;
Klose et al., 2006; Whetstine et al., 2006) and KDM6B (alsoCell Stem Cell 11,known as JMJD3; Lan et al., 2007; Agger
et al., 2007), through Smad signaling. The
knockdown of either KDM4B or KDM6B
impaired osteogenic commitment of
MSCs in vitro and in vivo whereas adipo-
genic lineage commitment of MSCs
was enhanced. Mechanistically, while
KDM6B was required for the expressionof HOX genes by removing histone 3 K27 trimethylation
(H3K27me3), KDM4B regulated the expression of DLX genes
by removing histone 3 K9 trimethylation (H3K9me3). Intriguingly,
we found that H3K27me3 and H3K9me3 marks were signifi-
cantly increased in bone marrow MSCs of ovariectomized
mice or aging mice in which adipogenesis was significantly
elevated.
RESULTS
Induction of KDM4B and KDM6B by BMP-4/7 through
Smad in MSCs
BMP-4/7 are potent inducers of osteogenic differentiation of
MSCs, offering a great promise for bone regeneration and re-
pair. To investigate potential roles of histone demethylases in
osteogenic differentiation of MSCs, we profiled expression of
28 histone demethylases in BMP-4/7-induced MSCs from
human bone marrow. Human MSCs used in our studies highly
expressed CD73, CD90, CD105, and CD146 and were negative
for CD34, CD45, and HLA (Figure S1, available online). Real-time
reverse transcriptase-polymerase chain reaction (real-time RT-
PCR) revealed that KDM4B and KDM6B were most strongly
induced by BMP4/7 (Figure 1A). KDM4B and KDM6B are histone
demethylases that remove H3K9me3 and H3K27me3, respec-
tively (Fodor et al., 2006; Cloos et al., 2006; Klose et al., 2006;
Whetstine et al., 2006; Lan et al., 2007; Agger et al., 2007).
Both H3K9me3 and H3K27me3 are associated with gene
silencing. Previously, KDM6B was identified as an early
response gene induced by LPS through NF-kB signaling in
macrophages (De Santa et al., 2007). Since BMPs mainly induce50–61, July 6, 2012 ª2012 Elsevier Inc. 51
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Figure 2. KDM6B Is Required for Osteo-
genic Differentiation of MSCs
(A) Overexpression of KDM6B in MSCs.
(B) Overexpression of KDM6B enhanced ALP
activities inMSC differentiation. Values aremean ±
SD for triplicate samples from a representative
experiment. **p < 0.01.
(C) The overexpression of KDM6B enhanced
mineralization in MSC differentiation. Mineraliza-
tion was stained with Alizarin Red and qualitatively
measured. **p < 0.01.
(D) The knockdown of KDM6B by shRNA. MSC/
KDM6Bsh, MSCs expressing KDM6B shRNA;
MSC/Scrsh, MSCs expressing scramble shRNA.
(E) The knockdown of KDM6B inhibited ALP
activities in MSCs. Values are mean ± SD for
triplicate samples from a representative experi-
ment. **p < 0.01.
(F) The knockdown of KDM6B inhibited minerali-
zation in MSCs. **p < 0.01.
(G) The knockdown of KDM6B inhibited IBSP
expression in MSCs as determined by real-time
RT-PCR. **p < 0.01.
(H) The knockdown of KDM6B inhibited SPP1
expression in MSCs as determined by real-time
RT-PCR. **p < 0.01.
(I) The knockdown of KDM6B inhibited BGLAP
expression in MSCs as determined by real-time
RT-PCR. **p < 0.01.
(J) The restoration of KDM6B and mutant KDM6B
in Kdm6b knockdown MSCs by western blot
analysis.
(K) The catalytically mutant KDM6B could not
restore the expression of osteoblast marker genes
in MSCs.
(L) The catalytically mutant KDM6B could not
restore ALP activities in MSCs.
(M) The knockdown of KDM6B inhibited BMP-
enhanced ALP activities in MSCs. **p < 0.01.
(N) The knockdown of KDM6B inhibited BMP-
enhanced mineralization in MSCs. **p < 0.01. See
also Figure S2.
Cell Stem Cell
Epigenetic Control of MSC Fategene expression through SMAD signaling (Feng and Derynck,
2005; Attisano and Wrana, 2002; Massague´ et al., 2005), we
examined whether the inductions of KDM4B and KDM6B
was dependent on SMAD signaling. Lentiviruses expressing
SMAD4 shRNAwere generated to knock downSMAD4.Western
blot analysis showed that more than 85% SMAD4 was depleted
inMSCs expressing SMAD4 shRNA (MSC/SMAD4sh) compared
with MSCs expressing scramble shRNA (MSC/Scrsh) (Fig-
ure 1B). Real-time RT-PCR revealed that knockdown of
SMAD4 significantly reduced the expression of KDM4B and
KDM6B in MSCs induced by BMP4/7 (Figures 1C and D).
Furthermore, the knockdown of SMAD1, a key factor associated
with BMP signaling, also inhibited the expression of KDM4B and
KDM6B induced by BMP4/7 (Figures 1E–1G).
KDM4B and KDM6B Are Required for Osteogenic
Differentiation of MSCs
Since KDM4B and KDM6B were induced by BMP4/7, we
explored whether they played a role in MSC cell fate determina-52 Cell Stem Cell 11, 50–61, July 6, 2012 ª2012 Elsevier Inc.tion. MSCs can be differentiated into osteoblasts, chondrocytes,
and adipocytes in vitro depending on the culture conditions.
When stimulated by culturemedium containing dexamethasone,
b-glycerophosphate, and inorganic phosphate, MSCs can be
induced to undergo osteogenic differentiation in vitro (Gronthos
et al., 1994; Fan et al., 2009). We overexpressed KDM6B in
human MSCs (Figure 2A). After osteogenic induction, we found
that overexpression of KDM6B significantly enhanced alkaline
phosphatase (ALP) activity, an early marker of osteoblast differ-
entiation (Figure 2B). Consistently, overexpression of KDM6B
enhanced mineralization in vitro, as assessed by Alizarin
Red staining (Figure 2C). Similarly, we found that overexpression
of KDM4B also enhanced ALP activity and mineralization in
MSCs (Figures 3A–3C).
To examine whether KDM4B and KDM6B played important
roles in osteogenic differentiation of MSCs, we generated lentivi-
ruses expressing KDM4B or KDM6B shRNA. The knockdown
of KDM6B in MSCs was confirmed using Real-time RT-PCR
(Figure 2D). After treating MSCs with osteogenic inducing media
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Figure 3. KDM4B Is Required for Osteo-
genic Differentiation of MSCs
(A) Overexpression of KDM4B in MSCs. MSC/
KDM6B, MSCs expressing KDM6B; MSC/V,
MSCs expressing empty vector.
(B) Overexpression of KDM4B enhanced ALP
activities inMSC differentiation. Values aremean ±
SD for triplicate samples from a representative
experiment. **p < 0.01.
(C) Overexpression of KDM4B enhanced mineral-
ization in MSC differentiation. **p < 0.01.
(D) The knockdown of KDM4B by shRNA. MSC/
KDM4Bsh, MSCs expressing KDM4B shRNA;
MSC/Scrsh, MSCs expressing scramble shRNA.
(E) The knockdown of KDM4B inhibited ALP
activities in MSCs. Values are mean ± SD for trip-
licate samples from a representative experiment.
**p < 0.01.
(F) Knockdown of KDM4B inhibited mineralization
in MSCs. **p < 0.01.
(G) Knockdown of KDM4B inhibited BGLAP
expression in MSCs as determined by real-time
RT-PCR. **p < 0.01.
(H) Knockdown of KDM4B inhibited BMP-
enhanced ALP activities in MSCs. **p < 0.01.
(I) Knockdown of KDM4B inhibited BMP-
enhanced mineralization in MSCs. **p < 0.01. See
also Figure S3.
Cell Stem Cell
Epigenetic Control of MSC Fatefor 4–5 days, ALP activity of differentiating MSCs was sig-
nificantly suppressed by knocking down KDM6B (Figure 2E).
Moreover, KDM6B knockdown also reduced formation of
mineralized nodules after prolonged treatment with inducing
media for 2 weeks (Figure 2F). To confirm that KDM6B depletion
inhibited osteogenic differentiation in MSCs, we assessed the
mRNA expression of several osteogenic markers 0, 10, and
14 days after induction. The knockdown of KDM6B significantly
inhibited the expression of IBSP (also known as bone sialopro-
tein or BSP), SPP1 (also known as osteopontin or OPN), and
BGLAP (also known as osteocalcin or OCN) (Figures 2G–2I).
Moreover, to rule out off-target effects, we made another vector
targeting a different region of KDM6B and obtained similar
results (Figures S2A–S2C). We found that the knockdown of
Kdm6b in mouse MSCs also inhibited osteogenic differentiation.
InmouseMSC/Kdm6bsh, the overexpression of humanKDM6B,
which was resistant to mouse Kdm6sh shRNA, restored osteo-
genic differentiation of MSCs (Figures S2D–S2G). Elegant
studies by Miller et al. (Miller et al., 2008, 2010; Miller and Wein-
mann, 2010) showed that KDM6B may function independently
from its demethylase activity to achieve chromatin remodeling
of its target genes in T cell commitment. To test this possibility,
we generated a catalytically-dead KDM6B mutant in which
histidin 1390 was changed to alanine, disrupting the nonheme
center for its demethylase activity. However, the overexpression
of KDM6B, but not the catalytically mutant KDM6B in mouse
MSC/Kdm6sh rescued osteogenic differentiation of MSCs
(Figures 2J–2L), indicating that KDM6B demethylase activity isCell Stem Cell 11,required for MSC differentiation. It is
well known that addition of exogenous
BMPs enhances osteogenic differentia-
tion in MSCs. More importantly, sinceKDM6B was induced by BMP4, we examined whether the
depletion of KDM6B would affect BMP4/7 enhancement. As
shown in Figures 2M and 2N, the knockdown of KDM6B sig-
nificantly suppressed osteogenic differentiation of MSC induced
by BMP4/7. Consistently, the knockdown of KDM6B inhibited
the expression of RUNX2 and SP7 (also known as OSX) induced
by BMP4/7 (Figures S2H and S2I).
We also utilized shRNA to knockdown KDM4B in MSCs. The
depletion of KDM4B inhibited ALP activity, mineralization and
expression of extracellular matrix proteins in MSCs stimulated
with osteogenic-inducing media (Figures 3D–3G). To rule out
off-target effects, we made another vector targeting different
region of KDM4B and obtained similar results (Figures S3A–
S3C). The restoration of KDM4B in MSC/KDM4Bsh cells, which
was resistant to KDM4B shRNA, also reinstated osteogenic
differentiation of MSCs (Figures S3D–S3F). The knockdown of
KDM4B also inhibited osteogenic differentiation of MSCs
enhanced by BMP4/7 (Figures 3H and 3I).
KDM4B and KDM6B Are Required for MSC-Mediated
Bone Formation In Vivo
To verify our in vitro findings, we examined whether the knock-
down of KDM4B and KDM6B affected MSC-mediated bone
formation in vivo. MSC/KDM4Bsh, MSC/KDM6Bsh, and MSC/
Scrsh were mixed with hydroxyapatite/tricalcium phosphate
(HA/TCP) carriers and then transplanted subcutaneously into
the dorsal side of 10-week-old nude mice. After 8 weeks, trans-
plants were harvested and prepared for histological analysis.50–61, July 6, 2012 ª2012 Elsevier Inc. 53
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Figure 4. KDM4B and KDM6B Are Required for
MSC-Mediated Bone Formation In Vivo
(A) Knockdown of KDM6B reduced MSC-mediated
bone formation in vivo. Scale bar represents 100 mm.
(B) Qualitative measurement of bone formation by
MSC/KDM6Bsh and MSC/V in vivo. Values are mean ±
SD, n = 5. **p < 0.01.
(C) Knockdown of KDM4B reduced MSC-mediated
bone formation in vivo. Scale bar represents 100 mm.
(D) Qualitative measurement of bone formation by
MSC/KDM4Bsh and MSC/V in vivo. Values are
mean ± SD, n = 5. **p < 0.01.
(E) Knockdown of KDM6B promoted adipogenic
differentiation of MSCs. MSC/Scrsh, MSCs express-
ing scramble shRNA; MSC/KDM6Bsh1, MSCs ex-
pressing KDM6B shRNA1; MSC/KDM6Bsh2, MSCs
expressing KDM6B shRNA2.
(F) Knockdown of KDM6B promoted PPARG expres-
sion as determined by real-time RT-PCR.
(G) Knockdown of KDM6B promoted CD36 expressing
as determined by real-time RT-PCR.
(H) Knockdown of KDM4B promoted PPARG ex-
pression as determined by real-time RT-PCR. MSC/
Scrsh, MSCs expressing scramble shRNA; MSC/
KDM4Bsh1, MSCs expressing KDM4B shRNA1;
MSC/KDM4Bsh2, MSCs expressing KDM4B shRNA2.
(I) Knockdown of KDM4B promoted CD36 expressing
as determined by real-time RT-PCR.
Cell Stem Cell
Epigenetic Control of MSC FateH&E staining showed that MSC/KDM4Bsh and MSC/KDM6Bsh
cells formed less bone tissues than MSC/Scrsh cells (Figures 4A
and 4C). Quantitative measurement of mineralized tissue areas
revealed a greater than 50% decrease in bone formation by
MSC/KDM4Bsh or MSC/KDM6Bsh cells compared with MSC/
Scrsh cells (Figures 4B and 4D). Interestingly, although it was
difficult to perform qualitative measurement, we noted that
adipose tissue formation in some regions was increased in
MSC/KDM4B or MSC/KDM6B transplants as compared with
MSC/Scrch transplants (Figures 4A and 4C, bottom right panel),
suggesting that KDM4B and KDM6B may inhibit adipogenic
differentiation of MSCs.
Inhibition of Adipocyte LineageCommitment ofMSCs by
KDM4B and KDM6B
As normal bone homeostasis relies on the dynamic balance
between osteogenesis and adipogenesis in differentiating
MSCs, an osteogenic lineage commitment could be coupled
with an inhibition of adipogenic differentiation. To explore
whether KDM4B and KDM6B regulated adipogenic differentia-
tion of MSCs, we assessed phenotypical changes of MSC/54 Cell Stem Cell 11, 50–61, July 6, 2012 ª2012 Elsevier Inc.KDM4Bsh and MSC/KDM6Bsh cultured
with adipogenic inducing medium. Oil-red-O
staining revealed significant enhancement
of adipogenesis in MSC/KDM6B cells as
compared with MSC/Scrsh cells (Figure 4E).
To examine whether the early onset of
adipogenesis was influenced by KDM6B,
we quantified the mRNA levels of the master
adipogenic transcription factor PPARG. As
shown in Figure 4F, the depletion of KDM6B
significantly enhanced PPARG expression.CD36, also known as fatty acid translocase, is highly expressed
in adipocytes and is important in fatty acid uptake and lipid
accumulation. Its expression is induced by PPARG (Qiao
et al., 2008). The depletion of KDM6B significantly increased
CD36 expression over a longer period (Figure 4G). Consistently,
we found that the knockdown of KDM4B also enhanced adipo-
genic differentiation of MSCs (Figures 4H and 4I).
KDM4B and KDM6B Target Distinct Transcription
Factors to Induce MSC Cell Lineage Commitment
through H3K9me3 and H3K27me3
Previously, it was shown that KDM6B regulates the expression of
HOX and BMP genes in embryonic stem cell differentiation
through the removal of H3K27me3 (Lan et al., 2007; Agger
et al., 2007). Since HOX and BMP genes are implicated in
osteogenic differentiation, we tested whether the depletion of
KDM6B affected the endogenous expression of BMP and HOX
genes. Interestingly, in MSC/KDM6Bsh cells, the basal levels
of endogenous BMP2 and BMP4 were significantly suppressed
(Figures 5A and 5B). Consistently, the induction of RUNX2 was
inhibited upon induction of osteogenic differentiation (Figure 5C).
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Figure 5. KDM6B Is Required for BMP and
HOX Gene Expression in MSCs by Removal
of H3K27me3 Marks
(A and B) Knockdown of KDM6B inhibited the
basal levels of BMP2 and BMP4 expression as
determined by real-time RT-PCR.
(C) Knockdown of KDM6B inhibited RUNX2
expression during MSC differentiation.
(D–G) Knockdown of KDM6B inhibited the basal
levels of HOX gene expression in MSCs as as-
sessed real-time RT-PCR.
(H–J) Knockdown of KDM6B reduced KDM6B
binding to the promoters of BMP2, BMP4, and
HOXC6-1 in MSCs. The promoters of BMP2,
BMP4, and HOXC6-1 were ChIP-ed with anti-
KDM6B antibodies or IgG control. The 3 to 4 kb
downstream of the transcriptional start site was
also ChIPed with anti-KDM6B.
(K–M) Knockdown of KDM6B increased
H3K27me3 levels at the promoters of BMP2,
BMP4, and HOXC6-1. **p < 0.01. See also Figures
S4 and S5 and Tables S1–S3.
Cell Stem Cell
Epigenetic Control of MSC FateHOX genes encode a large family of homeodomain-containing
transcription factors that are implicated in anterior-posterior
axis patterning in embryonic development (Wacker et al., 2004;
Lan et al., 2007; Agger et al., 2007). Moreover, HOX transcription
factors were found to activate RUNX2 transcription and can
also mediate osteoblastogenesis in a RUNX2-independent
manner (Hassan et al., 2007). Real-time RT-PCR revealed that
the depletion of KDM6B significantly inhibited the expressions
of HOXC6-1, HOXA10, HOXB2, and HOXC10 (Figures 5D–5G),
implying that these HOX transcription factors may be regulated
by KDM6B, thereby playing roles in promoting the osteogenic
differentiation of MSCs. To further examine howKDM6B globally
controlled MSC differentiation, we also performed microarray
analysis on MSC/Scrsh and MSC/KDM6Bsh. KDM6B knock-
down significantly inhibited the expression of 1867 genes at
the basal level and 638 genes induced by BMP4/7, including
BMP2 and BMP4 as well as members of HOX family genes
(Figure S4). A gene ontology (GO) analysis revealed that
KDM6B controls the pathways associated with skeletal systemCell Stem Cell 11,development, development process, cell
morphogenesis, and extracellular matrix
organization (Tables S1, S2, and S3).
In order to examine whether KDM6B
regulated MSC differentiation by deme-
thylating H3K27me3, we performed
ChIP assay to assess the changes in
histone methylation status at the pro-
moter regions of those master differentia-
tion genes. Indeed, we found that KDM6B
bound to the promoter regions of BMP2
and BMP4 (Figures 5H and 5I). Since
our gain- and loss-of-function analysis
revealed that HOXC6-1 played a func-
tional role in osteogenic differentiation
of MSCs (Figures S5A–S5I), we also
examined the epigenetic status of the
HOXC6-1 promoter. KDM6B was alsofound to be present on the HOXC6-1 promoter (Figure 5J).
KDM6B occupancy on the promoters of BMP2, BMP4, and
HOXC6-1 was reduced in MSC/KDM6B cells (Figures 5H–5J).
Consistently, decreased binding of KDM6B at the promoter
regions was associated with increased occurrence of its sub-
strate, H3K27me3, which is a hallmark of gene silencing (Figures
5K–5M). As a control, we could not detect KDM6B occupancy
3 to 4 kb downstream of the transcription start sites, and the
knockdown of KDM6B did not affect H3K27me3 on that region.
Importantly, we found that knockdown of KDM6B decreased
H3 acetylation and the recruitment of RNA polymerase II on
the promoter of BMP2 and HOXC6-1 (Figures S5J–S5M), further
suggesting that KDM6B is required for osteogenic differentiation
of MSCs. However, despite our repeated efforts, we could not
detect KDM6B on the RUNX2 and SP7 promoter, suggesting
that KDM6B does not directly regulate the RUNX2 and SP7
expression.
To explore the molecular mechanisms underlying the regula-
tion of osteogenic differentiation by KDM4B, we performed50–61, July 6, 2012 ª2012 Elsevier Inc. 55
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Figure 6. KDM4B Is Required for DLX Gene
Expression in MSCs by Removal of
H3K9me3 Marks
(A–C) Knockdown of KDM4B inhibited the
expression of DLX5, DLX2, and DLX3 induced by
BMP4/7, as determined by real-time RT-PCR.
**p < 0.01.
(D) The knockdown of KDM4B inhibited SP7
expression induced by BMP4/7.
(E) BMP4/7 induced KDM4B binding to the DLX5
promoter. MSCswere treatedwith BMP4/7 for 4 hr
and the DLX5 promoter was ChIP-ed with anti-
KDM4B or IgG control. The 4 kb downstream of
the transcriptional start site was also ChIPed with
anti-KDM4B.
(F) BMP4/7 promoted the removal of H3K9me3 in
the DLX5 promoter.
(G) Knockdown of KDM4B inhibited the recruit-
ment of KDM4B to the DLX5 promoter.
(H) Knockdown of KDM4B abolished BMP-
induced removal of H3K9me3 marks at the DLX5
promoter. **p < 0.01. See also Figures S6 and S7
and Table S1–S3.
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Epigenetic Control of MSC FateReal-Time RT-PCR analysis to assess the expression of key
genes associated with osteogenic differentiation of MSCs. In
contrast to KDM6B, we found that the depletion of KDM4B
did not affect the basal levels of HOX genes (Figures S6A and
S6B). Interestingly, we observed that the depletion of KDM4B
significantly reduced DLX5 expression that was induced by
BMP4/7 (Figure 6A). The depletion of KDM4B also significantly
repressed expression of DLX2 and DLX3 induced by BMP4/7
(Figures 6B and 6C). Additionally, we found that KDM4B deple-
tion also inhibited SP7 expression, although SP7 induction was
slower than that that of DLX5 (Figure 6D). We also examined
how KDM4B globally controlled gene expression profile during
MSC differentiation using microarray analysis. KDM4B knock-
down inhibited the expression of 2448 genes at the basal level
and 643 genes induced by BMP4/7. Unlike the results from
KDM6B knockdown, the DLX family genes, including DLX2,
DLX3, DLX5, and DLX6, were mainly dependent on KDM4B
(Figure S7). The GO analysis also indicated that KDM4B
globally controls the expression of genes associated with
skeletal development and osteoblast differentiation (Tables
S4–S6). Of note, we found that there were some overlaps56 Cell Stem Cell 11, 50–61, July 6, 2012 ª2012 Elsevier Inc.between KDM4B- and KDM6B-depenent
genes. The demethylation of both
H3K27me3 and H3K9me3 might be
required for their transcription. However,
it also could be due to secondary effects
because KDM4B or KDM6B knockdown
impaired MSC differentiation through
master regulators and subsequently
affected common genes associated with
osteogenesis.
DLX family genes play critical roles in
osteoblast differentiation (Hassan et al.,
2004). Importantly, DLX5 has been found
to control SP7 expression (Lee et al.,2003). Since DLX5 was dramatically induced by BMP4/7, we
examined whether KDM4B directly regulated DLX5 expression
by removing H3K9me3 silencing marks using ChIP assays.
While KDM4B was induced to bind to the DLX5 promoter
(Figure 6E), H3K9me3 levels at the DLX5 promoter were sig-
nificantly reduced in MSCs following BMP4/7 treatment (Fig-
ure 6F). Moreover, the knockdown of KDM4B reduced
KDM4B binding to the DLX5 promoter induced by BMP4/7
(Figure 6G). Consistently, H3K9me3 levels on the DLX5 pro-
moter were not reduced in MSC/KDM4Bsh cells as compared
with MSC/Scrsh cells upon BMP4/7 treatment (Figure 6H).
As a control, KDM4B was not present 4 kb downstream of
the transcription start site, and the knockdown of KDM4B
did not affect H3K9me3 on that region (Figures 6G and 6H).
Since KDM4 family demethylases might help to remove
H3K36me3 marks, we also examined the levels of H3K36me3
on the DLX5 promoter. ChIP assays showed that KDM4B
knockdown did not affect H3K36me3 levels on the DLX5
promoter (Figure S6C). Importantly, knockdown of KDM4B
decreased H3 acetylation and the recruitment of RNA poly-
merase II on the DLX5 promoter, further implicating that
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Figure 7. H3K27me3 and H3K9me3 in MSCs
Are Significantly Increased in Osteoporotic
or Aging Bone Marrow of Mice
(A) The percentage of H3K27me3-positive MSCs
was increased in bonemarrow after OVX. The total
number of double nestin- and H3K27me3-positive
MSCs from five different fields were counted and
compared with the total number of nestin-positive
MSCs. n = 6; *p < 0.05.
(B) The percentage of H3K9me3-positive MSCs
was increased in bone marrow after OVX. n= 6,
*p < 0.05.
(C) Trabecular bones were decreased and adipose
tissues were increased in ageing mice by histo-
logical analysis. Scale bar represents 100 mm.
(D) Representative mCT image of bone loss in
aging mice. Scale bar represents 0.4 mm.
(E) BMD was reduced in ageing mice. n = 8,
*p < 0.05.
(F) Bone volume was reduced in aging mice.
*p < 0.05.
(G) Immunofluorescence double staining of
nestin- and H3K27me3- or H3K9me3-positive
MSCs in bone marrow from 2- and 18-month-old
mice. Nestin was stained red, and H3K27me3
or H3K9me3 was stained green. Yellow arrow,
MSCs double positive for nestin and H3K27me3
or H3K9me3; white arrow, nestin-positive and
H3K27me3- or H3K9me3-negative MSCs; rIgG,
rabbit IgG;mIgG,mouse IgG. Scale bar represents
25 mm.
(H) The percentage of H3K27me3-positive MSCs
was higher in aging mice. *p < 0.05.
(I) The percentage of H3K9me3-positive MSCs
was higher in aging mice. *p < 0.05. Scale bar
represents 25 mm.
(J) The expressions of Kdm4b and Kdm6b were
reduced in MSCs from agingmice. n = 3, *p < 0.05.
Cell Stem Cell
Epigenetic Control of MSC FateKDM4B is required for DLX5 gene transcription (Figures S6D
and S6E).
H3K27me3 and H3K9me3 Are Elevated in MSCs
of Osteoporotic Bone Marrow
MSCs in bone marrow can differentiate into either osteoblasts
or adipocytes, and there is an inverse relationship between
osteogenesis and adipogenesis in MSC differentiation (McCau-
ley, 2010; Takada et al., 2007, 2009; Kawai and Rosen, 2010).
Excessive adipogenic differentiation has been observed in
bone marrow of osteoporotic postmenopausal women (Meunier
et al., 1971; Justesen et al., 2001). Our results suggest that the
methylation status of H3K9me3 and H3K27me3may be a critical
epigenetic factor that determines MSC fate in bone marrow.
Previously, we showed that the adipogenesis was significantly
increased in the bonemarrow of mice with osteoporosis induced
by ovariectomy (OVX) (Chang et al., 2009). Based on our in vitroCell Stem Cell 11,studies, it is possible that H3K9me3
and H3K27me3 might be abnormally
elevated in bone marrow MSCs of
OVX-ed mice. To test this possibility
in vivo, we performed immunofluores-
cence double labeling to examine thestatus of H3K9me3 and H3K27me3 in bone marrow MSCs of
OVX-ed mice using anti-nestin antibodies and anti-H3K9me3
or anti-H3K27me3 antibodies. Very recently, elegant studies by
Me´ndez-Ferrer et al. (2010) showed that mouse MSCs ex-
pressed nestin, which can be utilized to directly detect MSCs
in mouse bone marrow. The total number of cells positive for
both nestin and H3K9me3 or H3K27me3 was counted and
compared with the total number of nestin-positive cells. Double
immunofluorescence labeling revealed that the percentage of
MSCs positive for both nestin and H3K9me3 or H3K27me3
was significantly higher in ovariectomized mice than in sham-
operated mice (Figures 7A and 7B).
In aging mice, adipogenesis is increased in bone marrow
whereas osteoblastogenesis is reduced (Muruganandan et al.,
2009). To further confirm that H3K9me3 and H3K27me3 are
associated with MSC fate commitments, we also examined their
status in bone marrow MSCs of aging mice. Compared with50–61, July 6, 2012 ª2012 Elsevier Inc. 57
Cell Stem Cell
Epigenetic Control of MSC Fateyounger, 2-month-old mice, we observed that adipose tissues
were significantly increased in the bone marrows of 18-month-
old mice (Figure 7C). mCT showed that the trabecular bone
was significantly reduced in 18-month-old mice as compared
with 2-month-old mice (Figures 7D–7F). Immnofluorescence
double labeling revealed that the percentage of MSCs positive
for both nestin and H3K9me3 or H3K27me3 was significantly
higher in 18-month-old mice than in 2-month-old mice (Figures
7G–7I). Despite repeated efforts, we could not costain nestin
with KDM4B and KDM6B in bone marrow using commercially
available antibodies. Thus, we isolated MSC from both young
and old mice. Real-time RT-PCR revealed that the expression
of KDM4B and KDM6B was significantly reduced in MSCs
from old mice compared to those from young mice (Figure 7J).
DISCUSSION
MSCshavemultiple differentiation potentials and canbe induced
to differentiate into osteoblasts or adipocytes. However, both
lineages are mutually exclusive (McCauley, 2010). The activation
of RUNX2, SP7, and DLX5 has been found to inhibit adipogene-
sis. Conversely, forced expression of PPARG inhibits osteogenic
differentiation of MSCs (Takada et al., 2007). The commitment of
MSCs to an osteogenic lineage requires coordinated inhibition of
differentiation toward other lineages, including the adipogenic
lineage. The activation of multiple transcription factors has
been identified to be associated with MSC differentiation (Lian
et al., 2006; Caplan, 2007; Levi and Longaker, 2011). To differen-
tiate into osteoblastic or adipogenic lineages, in theory, the chro-
matin of those genes needs to be reprogrammed or modified. In
this study, using gene expression profiling, we identified that
KDM4B and KDM6B played a critical role in MSC cell fate
commitment by removing H3K9me3 and H3K27me3 on different
sets of lineage-specific genes. TheHOX andDLX genes that play
essential roles in MSC osteogenic differentiation were found to
be regulated by KDM6B and KDM4B through the removal of
H3K27me3 and H3K9me3, respectively. More importantly, given
the inverse relationship between osteogenic and adipogenic
lineage commitment, we found that H3K9me3 and H3K27me3
marks were abnormally elevated in MSCs of osteoporotic bone
marrow in vivo. Our results provide the first demonstration that
histone demethylation controls the imbalance between osteo-
genesis and adipogenesis in metabolic bone diseases.
BMPs are potent inducers of osteogenic differentiation of
MSC that stimulate master transcription factors (Chen et al.,
2004). In this study, we provide insights into BMP-stimulated
MSC differentiation. The H3K27me3 gene silencing function is
essential for maintaining the balance between embryonic stem
cell (ESC) self-renewal and differentiation (Lan et al., 2007; Agger
et al., 2007). Decrease of H3K27me3 marks is associated with
embryonic development and ESC differentiation. It is possible
that chromatins of master differentiation genes in MSCs are
enriched with repressive H3K27me3 marks prior to lineage
commitment. Recently, Wei et al. (2011) found that the H3K27
methyltransferase EZH2 played an important role in the inhibition
of MSC differentiation. Interestingly, they found that EZH2
directly binds to the promoter of RUNX2. The inactivation of
EZH2 by CDK1-dependent phosphorylation reduced the levels
of H3K27me3 and promoted osteogenic differentiation of MSC58 Cell Stem Cell 11, 50–61, July 6, 2012 ª2012 Elsevier Inc.by inducing RUNX2. Although the knockdown of KDM6B in-
hibited RUNX2 expression, we found that KDM6B did not
directly bind to the promoter of RUNX2. As in the case of
ESCs, we found that KDM6B directly regulated the expression
of BMP and HOX genes by removing H3K27me3 marks. There-
fore, it is likely that KDM6B indirectly controls RUNX2 expression
through BMPs and HOX. Given the fact that KDM6B is also
induced by BMPs, our results suggest a possible feedback
system and that MSC fate commitment can be regulated at
multiple levels by modulating the levels of H3K27me3.
KDM4B has been characterized as being capable of selec-
tively reducing chromosomal H3K9me3 marks to H3K9me1
with the H3K9me2 state remaining unaltered (Fodor et al.,
2006; Cloos et al., 2006; Klose et al., 2006; Whetstine et al.,
2006). H3K9me3 marks are generally associated with gene
repression. Themajority of H3K9me3marks are found in inactive
regions of the genome, such as constitutive heterochromatin.
Whereas in some reports these marks are enriched in actively
transcribed regions of the genome, they are never at the
promoter regions of expressed genes (Barski et al., 2007; McE-
wen and Ferguson-Smith, 2010). Depletion of KDM4B homolog
inC. elegans led to a global increase in H3K9me3 levels and acti-
vated p53-mediated apoptosis (Whetstine et al., 2006).
However, we found that the knockdown of KMD4B did not affect
MSC apoptosis. Unlike KDM6B, KDM4B knockdown mainly in-
hibited the expression of DLX genes. Our results suggest that
KDM4B and KDM6B may target different transcription factors
by removing H3K9me3 or H3K27me27 marks, respectively.
DLX family transcription factors have been found to play a critical
role in the induction of RUNX2 and SP7 (Acampora et al., 1999;
Lee et al., 2003; Hassan et al., 2004). Although knockdown of
KDM4B inhibited SP7 expression, our ChIP assay was unable
to detect KDM4B binding to the SP7 promoter, thereby implying
an indirect regulation of SP7 expression through DLX.
Osteoporosis is one of the most common bone metabolic
diseases that are associated with a shift in MSC lineage
commitment, and bone loss is accompanied by increased
adipose tissues in the bone marrow cavity. Our immunostaining
revealed a significant higher percentage of H3K27me3- and
H3K9me3-positive MSCs in bone marrow of OVX-ed mice or
aging mice. These results suggest that increased H3K27me3
and H3K9me3 levels might play an important role in the devel-
opment of osteoporosis by influencing determination of MSC
fate choices in bone marrow. As a chemically modifiable
enzyme, KDM4B and KDM6B could be activated or deacti-
vated to regulate specific lineage decisions of MSCs, thereby
holding promising potentials as a therapeutic target for stem
cell-mediated regenerative medicine as well as the treatment
of human metabolic bone diseases such as osteoporosis.EXPERIMENTAL PROCEDURES
Cell Culture and Viral Infection
Primary human and mouse MSCs were purchased from Texas A&M Health
Science Center College of Medicine Institute for Regenerative Medicine at
Scott & White Hospital. Viral packaging and infection was prepared as
described previously (Fan et al., 2009; Park et al., 2007). The target sequences
for shRNA were: KDM6Bsh1, 50-GCAGTCGGAAACCGTTCTT-30; KDM6Bsh2,
50-GTGGGAACTGAAATGGTAT-30; KDM4Bsh1, 50-CCTGCCTCTAGGTTCA
TAA-30; and KDM4Bsh3, 50-GCTACGAAGTGAACTTCGA-30.
Cell Stem Cell
Epigenetic Control of MSC FateALP, Alizarin Red Staining, and Oil-Red Staining
To induce MSC differentiation, we grew MSCs in mineralization-inducing
media containing 100 mM/ml ascorbic acid, 2 mM b-glycerophosphate, and
10 nM dexamethasone. ALP activity assay and Alizarin Red staining were per-
formed as described previously (Chang et al., 2009). To induce adipogenic
differentiation, we cultured MSCs in adipogenic-inducing media containing
0.5 mM isobutylmethylxanthine, 0.5 mM hydrocortisone, and 60 mM indometh-
acin (Sigma-Aldrich). Media were changed every 3 days. After 3 weeks of
culture in vitro, Oil-Red-O staining was performed to detect the lipid droplets
using an OIL-RED-O STAIN KIT according to the manufacturer’s instruction
(DBS, Pleasanton, CA, USA).
Real-Time RT-PCR
Total RNA was isolated from MSCs using Trizol reagents (Invitrogen). Two
microgram aliquots of RNAs were synthesized using random hexamers and
reverse transcriptase according to the manufacturer’s protocol (Invitrogen).
The real-time PCR reactions were performed using the QuantiTect SYBR
Green PCR kit (Qiagen) and the Icycler iQMulti-color Real-time PCRDetection
System. The primers for 18S rRNA are: forward, 50-CGGCTACCACATCCAAG
GAA-30; reverse, 50-GCTGGAATTACCGCGGCT-30. The primers for SPP1 are:
forward, 50-ATGATGGCCGAGGTGATAGT-30; reverse, 50-ACCATTCAACTC
CTCGCTTT-30. The primers for BGLAP are: forward, 50-AGCAAAGGTGC
AGCCTTTGT-30; reverse, 50-GCGCCTGGGTCTCTTCACT-30. The primers
for ALPL are: forward, 50-GACCTCCTCGGAAGACACTC-30; reverse: 50-TG
AAGGGCTTCTTGTCTGTG-30. The primers for IBSP are: forward, 50-CAGGC
CACGATATTATCTTTACA-30; reverse: 50-CTCCTCTTCTTCCTCCTCCTC-30.
The primers for HOXC6-1 are: forward, 50-CGGATAAGGGAGTCGAGT
AGATCCG-30; reverse, 50-TGAGGCATTTCTCGACCTATGG-30. The primers
for DLX5 are: forward, 50-CGCTAGCTCCTACCACCAGT-30; reverse, 50-GG
CTCGGTCACTTCTTTCTC-30. The primers for DLX2 are: forward, 50-CCTGA
GAAGGAGGACCTTGA-30; reverse, 50-TTCCGGACTTTCTTTGGCT-30. The
primers forKDM6B are: forward, 50-CTCAACTTGGGCCTCTTCTC-30; reverse,
50-GCCTGTCAGATCCCAGTTCT-30. The primers for KDM4B are: forward,
50-CGGGTTCTATCTTTGTTTCTCTCACCCG-30; reverse, 50-AAGGAAGCCTC
TGGAACACCTG-30. The primers for PPARG are: forward, 50-CGAGACCAA
CAGCTTCTCCTTCTCG-30; reverse, 50-TTTCAGAAATGCCTTGCAGTGGT-30.
The primers for CD36 are: forward, 50-CGATTAACATAAGTAAAGTTGCC
ATA-30; reverse, 50-CGCAGTGACTTTCCCAATAGGAC-30. The primers for
histone demethylase profiling are provided in the Supplemental Information.
Microarray Procedure and Data Analysis
MSCs were treated with 150 ng/ml BMP4/7 for 0, 4, and 24 hr, respectively.
The extraction of total RNA was performed with miRNeasy kit (Qiagen) per
manufacturers’ instructions. One microgram of RNA from each sample was
hybridized to Affymetrix U133 Plus 2.0 Arrays at the UCLA DNA Microarray
Facility. Differential gene expression analysis was performed based on the
generated metadata txt file. >1.6-fold change in expression was considered
significant. To investigate enriched biological functions associated with
KDM4B/KDM6B-dependent genes, we performed GO analysis using the on-
line Database for Annotation, Visualization and Integration Discovery (DAVID)
Bioinformatics Resources v6.7. p values were calculated based on hypergeo-
metric distribution. Only significantly overexpressed (p < 0.05) GO terms were
included. Heatmap was generated via PermutMatrix v1.9.3 (Caraux and Pin-
loche, 2005) to reflect fold change relative to median expression of each
gene in Log2 ratio. Microarray data have been deposited in GEO under acces-
sion number GSE36970.
ChIP Assays
The assay was performed using a ChIP assay kit (Upstate, USA) according to
the manufacturer’s protocol as described previously (Fan et al., 2009). Data
are expressed as the percentage of input DNA. Antibodies for CHIP assays
were purchased from the following commercial sources: polyclonal anti-
KDM6B (Abgent, San Diego, CA); polyclonal anti-KDM4B (Millipore); poly-
clonal anti-H3K27me3 (Millipore); polyclonal anti-H3K9me3 (Abcam). The
primers for BMP2 are: forward, 50-TGGATCCCACGTCTATGCTA-30; reverse,
50-TCAGGGTCTGGCCTCTTATT-30; 4 kb downstream for BMP2: forward,
50-CAATCATAAGAATTACCTGTTGGG-30; reverse, 50-TGGTCGCATTATACT
CATATTGG-30. The primers for BMP4 are: forward: 50-CAGTTTATGGAAGGCCACCT-30; reverse, 50- GTAACTGCTGCCCAAACTGA-30; 4 kb downstream
for BMP4: forward, 50-TCTCTCCGGAATCGTCTCTC-30; reverse, 50-AGAA
GGTGGTCTGGGAGCTA-30. The primers for HOXC6-1 are: forward, 50-CG
TGATGGCATTTTCAGCCTATATCACG-30; reverse, 50-GAAACAGCGGAAAG
TGTGCAG-30; 3 kb downstream for HOXC6-1: forward, 50-CATTTATCAAC
CCTGGCCTT-30; reverse, 50-GACCCTCCTCAACACCTCTC-30. The primers
for DLX5 are: forward, 50-GGATTTCGGGAGTTTCCATT-30; reverse, 50-CG
GAGTCGCCAGAAATAAAG-30; 4 kb downstream for DLX5: forward, 50-CCA
AGAGCTGCAGTCAGATT-30; reverse, 50-CCGTCCTACTCCCTTCACTC-30.
Transplantation, Immunostaining, and mCT Analysis of Mice
The animal experiments were performed in accordance with the approved
animal protocol by The University of California, Los Angeles. Transplantation
in nude mice was performed as previously described (Fan et al., 2009). For
quantification of mineralized tissue, three pictures of each sample were taken
randomly (Olympus 103NA 0.25, 403NA 0.6). SPOT 4.0 software (Diagnostic
Instruments) was used to measure the area of mineralized tissue versus total
area (Chang et al., 2009).
For immunostaining in ovaiectomized mice, we utilized the sections of
femurs from previous studies (Chang et al., 2009). For aging studies, femurs
were harvested from 2-month-old and 18-month-old mice and fixed in 10%
neutral buffered formalin for 24 hrs. mCT scanningwas performed as described
previously (Chang et al., 2009). After scanning, the specimenswere decalcified
and sectioned. For immunofluorescence double staining, antigen retrieval was
performed as described previously (Chang et al., 2009). The sections were
incubatedwithmonoclonal anti-nestin (Lifespan BioSciences, 1:500) and poly-
clonal anti-H3K9me3 (Abcam, 1:500) or polyclonal anti-H3K27me3 (Millipore,
1:500) at 4C overnight. After washing with PBS solution three times, the
sections were incubated with appropriate Cy2 (red) and Cy3 (green) conju-
gated secondary antibodies (Jackson ImmunoResearch, 1:100) in darkness
at room temperature for 1 hr. The sections were imaged with a confocal laser
scanning microscope (Leica TCS-SP inverted), and the Leica Confocal Soft-
ware (LCS version 2.61 Build 1537).
ACCESSION NUMBERS
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under accession number GSE36970.
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